Free Trial

Avadel Pharmaceuticals (AVDL) Competitors

Avadel Pharmaceuticals logo
$11.08 +0.57 (+5.42%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$11.02 -0.05 (-0.50%)
As of 08/1/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVDL vs. KRYS, MTSR, ABVX, ZLAB, AKRO, ACLX, ACAD, VKTX, SRRK, and PTCT

Should you be buying Avadel Pharmaceuticals stock or one of its competitors? The main competitors of Avadel Pharmaceuticals include Krystal Biotech (KRYS), Metsera (MTSR), Abivax (ABVX), Zai Lab (ZLAB), Akero Therapeutics (AKRO), Arcellx (ACLX), ACADIA Pharmaceuticals (ACAD), Viking Therapeutics (VKTX), Scholar Rock (SRRK), and PTC Therapeutics (PTCT). These companies are all part of the "pharmaceutical products" industry.

Avadel Pharmaceuticals vs. Its Competitors

Krystal Biotech (NASDAQ:KRYS) and Avadel Pharmaceuticals (NASDAQ:AVDL) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Krystal Biotech presently has a consensus target price of $211.33, suggesting a potential upside of 34.62%. Avadel Pharmaceuticals has a consensus target price of $18.33, suggesting a potential upside of 65.46%. Given Avadel Pharmaceuticals' higher probable upside, analysts clearly believe Avadel Pharmaceuticals is more favorable than Krystal Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Krystal Biotech
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
Avadel Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Krystal Biotech had 13 more articles in the media than Avadel Pharmaceuticals. MarketBeat recorded 16 mentions for Krystal Biotech and 3 mentions for Avadel Pharmaceuticals. Avadel Pharmaceuticals' average media sentiment score of 1.18 beat Krystal Biotech's score of 0.74 indicating that Avadel Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Krystal Biotech
8 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avadel Pharmaceuticals
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Krystal Biotech has a net margin of 37.17% compared to Avadel Pharmaceuticals' net margin of -13.58%. Krystal Biotech's return on equity of 14.64% beat Avadel Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Krystal Biotech37.17% 14.64% 13.28%
Avadel Pharmaceuticals -13.58%-36.07%-16.30%

Krystal Biotech has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, Avadel Pharmaceuticals has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

86.3% of Krystal Biotech shares are held by institutional investors. Comparatively, 69.2% of Avadel Pharmaceuticals shares are held by institutional investors. 13.7% of Krystal Biotech shares are held by insiders. Comparatively, 5.2% of Avadel Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Krystal Biotech has higher revenue and earnings than Avadel Pharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Krystal Biotech$290.52M15.62$89.16M$4.1637.74
Avadel Pharmaceuticals$169.12M6.34-$48.83M-$0.27-41.04

Summary

Krystal Biotech beats Avadel Pharmaceuticals on 13 of the 16 factors compared between the two stocks.

Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVDL vs. The Competition

MetricAvadel PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.02B$2.47B$5.47B$9.53B
Dividend YieldN/A1.81%4.74%4.08%
P/E Ratio-41.048.9728.6723.80
Price / Sales6.34639.64422.2688.08
Price / CashN/A157.7635.4557.96
Price / Book14.394.838.275.55
Net Income-$48.83M$31.62M$3.24B$259.03M
7 Day Performance0.45%-5.28%-3.63%-4.56%
1 Month Performance25.77%4.38%4.40%4.49%
1 Year Performance-32.15%-2.49%25.97%18.05%

Avadel Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVDL
Avadel Pharmaceuticals
2.6701 of 5 stars
$11.08
+5.4%
$18.33
+65.5%
-32.9%$1.02B$169.12M-41.0470News Coverage
Positive News
Upcoming Earnings
KRYS
Krystal Biotech
4.8858 of 5 stars
$152.91
+3.6%
$211.33
+38.2%
-21.0%$4.27B$290.52M32.88210Upcoming Earnings
MTSR
Metsera
N/A$39.43
-2.6%
$55.00
+39.5%
N/A$4.25BN/A0.0081Earnings Report
Lockup Expiration
Analyst Revision
Gap Down
ABVX
Abivax
3.5887 of 5 stars
$66.57
+0.1%
$80.00
+20.2%
+511.7%$4.22BN/A0.0061Analyst Forecast
Gap Down
ZLAB
Zai Lab
2.1983 of 5 stars
$38.69
+4.1%
$54.28
+40.3%
+99.7%$4.13B$398.99M0.001,869News Coverage
Positive News
Upcoming Earnings
Short Interest ↑
Gap Up
AKRO
Akero Therapeutics
3.9446 of 5 stars
$49.24
-2.6%
$82.50
+67.5%
+83.6%$4.03BN/A0.0030Positive News
Upcoming Earnings
ACLX
Arcellx
2.5739 of 5 stars
$70.59
-1.0%
$111.23
+57.6%
+21.3%$3.93B$107.94M0.0080News Coverage
Positive News
Analyst Forecast
ACAD
ACADIA Pharmaceuticals
3.988 of 5 stars
$22.62
-2.7%
$28.13
+24.3%
+23.9%$3.89B$957.80M34.19510News Coverage
Upcoming Earnings
Analyst Revision
VKTX
Viking Therapeutics
3.7591 of 5 stars
$33.20
-3.5%
$86.92
+161.8%
-40.2%$3.87BN/A0.0020Short Interest ↑
SRRK
Scholar Rock
3.7908 of 5 stars
$37.09
-4.8%
$42.67
+15.0%
+301.3%$3.70B$33.19M0.00140News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
PTCT
PTC Therapeutics
4.482 of 5 stars
$44.36
-0.9%
$65.77
+48.3%
+59.5%$3.55B$806.78M6.171,410Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners